There is compelling evidence that carcinogenesis is a multistep process and multiple genetic lesions are necessary to develop cancer in human. Along the genetic lesions, the alteration of p53 protein (due to mutation of p53 gene or by infection of """"""""high risk"""""""" human papillomaviruses [HPV], e.g., type 16 or 18 HPV) is the most frequently found genetic disorder in human cancers including oral cancer. A significant body of evidence supports p53 mutation as an early event in oral carcinogenesis. Our studies have also shown that human oral keratinocytes (HOK) containing negligible amount of wild-type (wt) p53 protein (because of HPV DNA integration) and HOK expressing mutant (mt) p53 protein are immortal, but not tumorigenic. These cells convert to tumorigenic cells when exposed to tobacco-carcinogens. whereas cells with a normal complement of p53 do not, indicating that p53 dysfunction appears to be an early event in oral carcinogenesis. Therefore, the dysfunction of p53 protein appears be an early event at least in oral carcinogenesis and also be necessary for subsequent genetic disorders of other genes to convert normal cells to tumor cells in the human oral cavity. Inasmuch as wt p53 protein plays a major role in the regulation of cell cycle arrest, we hypothesize that normal human oral keratinocytes containing wt p53 protein repair damaged DNA more efficiently than oral keratinocytes with defective p53 function. As demonstrated by many studies including our preliminary data, cells expressing wt p53 protein have the ability to establish transient delays in the progression of cell cycle when exposed to genotoxic agents, but cells with defective p53 function do not possess such ability. Since the transient arrest of the cell cycle progression is necessary to repair damaged DNA prior to replication of damaged DNA template and segregation of damaged chromosome, cells with defective p53 function may fail or have limited ability to repair the damaged DNA when exposed to genotoxic agents. In the proposed study, we will test the above hypothesis by determining the effect of major tobacco- carcinogens on (1) the progression of cell cycle, the expression of major growth arrest and DNA damage inducible genes (e.g., p53, WAF1/CIP1, and gadd45), and the activity of cyclin-dependent kinases (cdks); (2) the genotoxicity of host chromosomal DNA (DNA adducts and single strand DNA breaks); (3) the repair of damaged DNA; and (4) the mutation frequencies and spectrum in normal HOK expressing wt p53, HOK expressing HPV-16 or HPV-18 E6 protein, HOK expressing mutant p53 protein, and HPV-immortalized oral keratinocytes. These proposed studies should help us gain more insight into molecular mechanisms of tobacco-related oral carcinogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE011229-03
Application #
2458634
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Project Start
1995-09-15
Project End
1999-07-14
Budget Start
1997-07-15
Budget End
1998-07-14
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Dentistry
Type
Schools of Dentistry
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Park, N H; Guo, W; Kim, H R et al. (2001) c-Myc and Sp1/3 are required for transactivation of hamster telomerase catalytic subunit gene promoter. Int J Oncol 19:755-61
Guo, W; Okamoto, M; Lee, Y M et al. (2001) Enhanced activity of cloned hamster TERT gene promoter in transformed cells. Biochim Biophys Acta 1517:398-409
Guo, W; Okamoto, M; Park, N H et al. (2001) Cloning and expression of hamster telomerase catalytic subunit cDNA. Int J Mol Med 8:73-8
Kim, H J; Guo, W; Park, N H (2000) HPV-16 E6 oncoprotein induces mutations via p53-dependent and -independent pathways. Oncol Rep 7:707-12
Itakura, M; Mori, S; Park, N H et al. (2000) Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis. Int J Oncol 16:591-7
Rey, O; Lee, S; Baluda, M A et al. (2000) The E7 oncoprotein of human papillomavirus type 16 interacts with F-actin in vitro and in vivo. Virology 268:372-81
Rey, O; Lee, S; Park, N H (2000) Human papillomavirus type 16 E7 oncoprotein represses transcription of human fibronectin. J Virol 74:4912-8
Min, B M; Woo, K M; Lee, G et al. (1999) Terminal differentiation of normal human oral keratinocytes is associated with enhanced cellular TGF-beta and phospholipase C-gamma 1 levels and apoptotic cell death. Exp Cell Res 249:377-85
Rey, O; Lee, S; Park, N H (1999) Impaired nucleotide excision repair in UV-irradiated human oral keratinocytes immortalized with type 16 human papillomavirus genome. Oncogene 18:6997-7001
Guo, W; Liu, X; Lee, S et al. (1999) High O6-methylguanine methyl transferase activity is frequently found in human oral cancer cells with p53 inactivation. Int J Oncol 15:817-21

Showing the most recent 10 out of 15 publications